Home » Topics » BioWorld Science

BioWorld Science
RSS

Auckland Uniservices divulges CSF1R inhibitors

May 30, 2018

U.S. researchers patent ITGA4 antagonists

May 30, 2018

FDA accepts NDA for larotrectinib and grants priority review

May 30, 2018

FDA accepts NDA and grants priority review status for Firdapse

May 30, 2018

European Commission grants authorization to Rubraca for recurrent ovarian cancer

May 30, 2018

ITGA3 suggested as a therapeutic target in bladder cancer

May 30, 2018

Pivotal phase III of chidamide in combination with exemestane reaches primary endpoint

May 30, 2018

Clinical trial authorization received in U.K. to initiate phase I study with OLX-10010

May 30, 2018

Xalkori receives FDA breakthrough therapy designation in two new indications

May 30, 2018

Tavalisse becomes available in the U.S.

May 30, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...